New Opportunities in Pancreatic Cancer at Clínic

Research in targeted therapies and advanced surgery opens new avenues for patients with complex tumors.

Generic image of a DNA double helix in a medical research laboratory.
AI

Generic image of a DNA double helix in a medical research laboratory.

The Clínic de Barcelona is advancing targeted therapies and complex surgical techniques to improve outcomes for pancreatic cancer patients, an aggressive disease often diagnosed late.

Pancreatic cancer, known for its aggressiveness and early spread, is seeing significant therapeutic advancements. On World Pancreatic Cancer Day, the importance of referring patients to specialized centers for access to new targeted therapies, clinical trials, and high-complexity surgical techniques is being emphasized.
New RAS inhibitors, targeting a key pathway in tumor growth, are showing promising results. Dr. Teresa Macarulla, head of Medical Oncology at Clínic, highlights these drugs as a therapeutic revolution. The RASolute 304 trial is evaluating the daraxonrasib inhibitor as adjuvant treatment after surgery to reduce relapse risk, building on hopeful results seen in metastatic disease.
The possibility of a second opinion is crucial. The case of Magdalena, who traveled from Mallorca to Clínic via the CSUR network, illustrates how an initially inoperable tumor can become treatable with prior therapies and specialized evaluations. Dr. Elizabeth Pando, a surgeon in the Hepatobiliary Pancreatic and Transplant Surgery Unit, stresses that a second opinion can open new opportunities.
Clínic, accredited as a CSUR center for surgical treatment of borderline resectable pancreatic cancer, has performed 50 pancreatic resections by mid-October 2026, surpassing last year's total. The Multidisciplinary Committee has evaluated 167 cases between March and October.
Integrated patient care is paramount, involving oncology, surgery, nursing, psycho-oncology, and palliative care. The specialized oncology nurse plays a central role in coordinating care and ensuring human and close support.
Based on information from the official source: Hospital Clínic de Barcelona (19/11/2026)